Product Information
LORATADINE-D 24HR TABLET is a generic product labeled by Major Pharmaceuticals, priced at $0.5535 per EA under NDC 00904583348. Its NADAC has been published 671 times since Nov 28, 2013.
FDA first approved this application on Sep 22, 2004.
Strength
10; 240 mg/1; mg/1
Manufacturer
Major PharmaceuticalsNDC
00904583348
Classification
Generic
Dosage Form
TABLET, FILM COATED, EXTENDED RELEASE
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
LORATADINE; PSEUDOEPHEDRINE SULFATEApproval Type
Generic (ANDA)
FDA Application
ANDA076557FDA Approved
9/22/2004
On Market Since
11/17/2004
Pharmacological Classes
Price Statistics
The NADAC for LORATADINE-D 24HR TABLET has been published 671 times since Nov 28, 2013, and over the history we have for it it has risen 30.3%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.5535 per EA |
|---|---|
| All-time high | $0.5950 (Nov 13, 2024) |
| All-time low | $0.3826 (Sep 20, 2017) |
| 52-week high | $0.5851 |
| 52-week low | $0.5307 |
| Median price | $0.4919 |
| Average price | $0.4950 |
| Largest weekly change | +21.7% (Aug 21, 2024) |
| Weeks tracked | 671 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
The matcher finds 4 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 9% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Major Pharmaceuticals manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Loratadine and Pseudoephedrine Sulfate market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
alpha-Adrenergic Agonist class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of LORATADINE-D 24HR TABLET?
The current National Average Drug Acquisition Cost (NADAC) for LORATADINE-D 24HR TABLET, manufactured by Major Pharmaceuticals, is $0.5535 per EA (NDC 00904583348), effective Sep 30, 2026.
How has the price of LORATADINE-D 24HR TABLET changed over time?
Over the history we have for it, the NADAC for LORATADINE-D 24HR TABLET has risen 30.3%. It has been tracked across 671 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for LORATADINE-D 24HR TABLET?
Since Nov 28, 2013, the NADAC for LORATADINE-D 24HR TABLET has ranged from a low of $0.3826 (Sep 20, 2017) to a high of $0.5950 (Nov 13, 2024), with a median of $0.4919 per EA.
Are there cheaper alternatives to LORATADINE-D 24HR TABLET?
Yes. 4 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, HM ALLERGY RLF-NASAL DECONG TB, is $0.5026 per EA — about 9% below LORATADINE-D 24HR TABLET.
Who manufactures LORATADINE-D 24HR TABLET?
LORATADINE-D 24HR TABLET (NDC 00904583348) is labeled by Major Pharmaceuticals, and CMS classifies it as a generic product.